News

Biopharma investors zero in on oncology and immunology | Health IT

By May 1, 2023No Comments

Biopharma investors are staying focused on the oncology and immunology sectors as major mergers fuel growth in those areas, according to an April 30 report from The Compass.

Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Biopharma investors zero in on oncology and immunology | Health IT

Tags:

Previous PostVA spending on Cerner EHR contract increased by 300% since 2018 | Health IT

Next PostAre Amazon Clinic patients HIPAA protected? | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us